What is the performance of biomarker-based scores in real-world clinical practice?
The performance of biomarker-based scores in real-world clinical practice (outside highly selected trial cohorts) has been disappointing, given that baseline (or near-baseline) determination of biomarkers to predict bleeding risks after many years is bedeviled by the changing clinical risk profile of patients' risks as well as modification of risk factors.